• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

单纯性高血压和II型糖尿病患者心脏细胞外基质周转血清标志物的早期变化。

Early changes in serum markers of cardiac extra-cellular matrix turnover in patients with uncomplicated hypertension and type II diabetes.

作者信息

Alla François, Kearney-Schwartz Anna, Radauceanu Anca, Das Dores Sylvie, Dousset Brigitte, Zannad Faiez

机构信息

Epidemiology Department (EA 3444), University Hospital, Nancy, France.

出版信息

Eur J Heart Fail. 2006 Mar;8(2):147-53. doi: 10.1016/j.ejheart.2005.06.008. Epub 2005 Sep 29.

DOI:10.1016/j.ejheart.2005.06.008
PMID:16198628
Abstract

AIMS

Extracellular matrix (ECM) turnover is a major determinant of diastolic dysfunction and pumping capacity, thus potentially contributing to the progression of congestive heart failure (CHF). Patients with both arterial hypertension and diabetes have a high risk of heart failure. Whether these patients have changes in cardiac ECM has not been studied previously. Our objective was to compare blood markers of collagen turnover among patients with CHF, patients with hypertension and type II diabetes (HD), and healthy individuals.

METHODS AND RESULTS

Measurements were performed in 239 CHF patients; 64 HD patients and 92 healthy subjects. We showed by adjusted ANOVA that PIIINP levels were significantly higher in CHF and HD patients than in controls, and higher in CHF patients than in HD patients. MMP1 levels were significantly lower in CHF and HD patients than in controls. Collagen type I markers (PICP and PINP) were not influenced by CHF but were lower in HD patients as compared to controls (p<0.05 for all comparisons).

CONCLUSION

In heart failure, markers of cardiac collagen synthesis are increased and markers of degradation are decreased, potentially contributing to cardiac fibrosis and thus to poor outcome. Changes in collagen turnover may also occur early in the disease process in high-risk patients before heart failure is clinically detectable.

摘要

目的

细胞外基质(ECM)周转是舒张功能障碍和泵血能力的主要决定因素,因此可能促进充血性心力衰竭(CHF)的进展。同时患有动脉高血压和糖尿病的患者心力衰竭风险很高。此前尚未研究过这些患者的心脏ECM是否有变化。我们的目的是比较CHF患者、高血压合并II型糖尿病(HD)患者和健康个体之间胶原周转的血液标志物。

方法与结果

对239例CHF患者、64例HD患者和92例健康受试者进行了测量。我们通过校正后的方差分析表明,CHF患者和HD患者的血清III型前胶原氨基端肽(PIIINP)水平显著高于对照组,且CHF患者高于HD患者。CHF患者和HD患者的基质金属蛋白酶1(MMP1)水平显著低于对照组。I型胶原标志物(前胶原I羧基端前肽(PICP)和前胶原I氨基端前肽(PINP))不受CHF影响,但HD患者低于对照组(所有比较p<0.05)。

结论

在心力衰竭中,心脏胶原合成标志物增加而降解标志物减少,这可能导致心脏纤维化,进而导致不良预后。在心力衰竭临床可检测之前,高危患者在疾病过程早期也可能发生胶原周转变化。

相似文献

1
Early changes in serum markers of cardiac extra-cellular matrix turnover in patients with uncomplicated hypertension and type II diabetes.单纯性高血压和II型糖尿病患者心脏细胞外基质周转血清标志物的早期变化。
Eur J Heart Fail. 2006 Mar;8(2):147-53. doi: 10.1016/j.ejheart.2005.06.008. Epub 2005 Sep 29.
2
Relation of circulating markers of fibrosis and progression of left and right ventricular dysfunction in hypertensive patients with heart failure.高血压心力衰竭患者循环纤维化标志物与左右心室功能障碍进展的关系。
J Hypertens. 2009 Dec;27(12):2483-91. doi: 10.1097/HJH.0b013e3283316c4d.
3
Relationship of circulating matrix biomarkers to myocardial matrix metabolism in advanced heart failure.循环基质生物标志物与晚期心力衰竭心肌基质代谢的关系。
Eur J Heart Fail. 2013 Mar;15(3):292-8. doi: 10.1093/eurjhf/hfs179. Epub 2012 Nov 9.
4
Collagen type-I degradation is related to arterial stiffness in hypertensive and normotensive subjects.I型胶原蛋白降解与高血压和血压正常受试者的动脉僵硬度有关。
J Hum Hypertens. 2006 Nov;20(11):867-73. doi: 10.1038/sj.jhh.1002015. Epub 2006 Apr 6.
5
Matrix metalloproteinases/tissue inhibitors of metalloproteinases: relationship between changes in proteolytic determinants of matrix composition and structural, functional, and clinical manifestations of hypertensive heart disease.基质金属蛋白酶/金属蛋白酶组织抑制剂:基质成分蛋白水解决定因素的变化与高血压性心脏病的结构、功能及临床表现之间的关系
Circulation. 2006 May 2;113(17):2089-96. doi: 10.1161/CIRCULATIONAHA.105.573865. Epub 2006 Apr 24.
6
Serum markers of collagen turnover predict future shocks in implantable cardioverter-defibrillator recipients with dilated cardiomyopathy on optimal treatment.血清胶原转换标志物可预测优化治疗的扩张型心肌病植入式心脏复律除颤器患者的未来电击事件。
J Am Coll Cardiol. 2010 Jun 15;55(24):2753-9. doi: 10.1016/j.jacc.2010.02.040.
7
Collagen metabolism in extracellular matrix may be involved in arterial stiffness in older hypertensive patients with left ventricular hypertrophy.细胞外基质中的胶原蛋白代谢可能与老年左心室肥厚高血压患者的动脉僵硬度有关。
Hypertens Res. 2005 Dec;28(12):995-1001. doi: 10.1291/hypres.28.995.
8
Serum carboxy-terminal propeptide of type I procollagen (PIP) is a marker of diastolic dysfunction in patients with early type 2 diabetes mellitus.
Int J Cardiol. 2007 Nov 30;122(3):e36-8. doi: 10.1016/j.ijcard.2007.07.057.
9
Serological evidence of early remodeling in high-risk non-ST elevation acute coronary syndromes.高危非ST段抬高型急性冠状动脉综合征早期重塑的血清学证据。
Int J Cardiol. 2008 Mar 28;125(1):22-7. doi: 10.1016/j.ijcard.2007.02.019. Epub 2007 Apr 12.
10
The relationship between serum galectin-3 and serum markers of cardiac extracellular matrix turnover in heart failure patients.心力衰竭患者血清半乳糖凝集素-3与心脏细胞外基质周转血清标志物之间的关系。
Clin Chim Acta. 2009 Nov;409(1-2):96-9. doi: 10.1016/j.cca.2009.09.001. Epub 2009 Sep 10.

引用本文的文献

1
Extracellular Matrix in Heart Disease: Focus on Circulating Collagen Type I and III Derived Peptides as Biomarkers of Myocardial Fibrosis and Their Potential in the Prognosis of Heart Failure: A Concise Review.心脏病中的细胞外基质:聚焦循环中的I型和III型胶原衍生肽作为心肌纤维化生物标志物及其在心力衰竭预后中的潜力:简要综述
Metabolites. 2022 Mar 28;12(4):297. doi: 10.3390/metabo12040297.
2
Role of strain echocardiography in patients with hypertension.应变超声心动图在高血压患者中的作用。
Clin Hypertens. 2022 Feb 15;28(1):6. doi: 10.1186/s40885-021-00186-y.
3
The relationship between serum fibrosis markers and restrictive ventricular filling in patients with heart failure with reduced ejection fraction: A technetium-99m radionuclide ventriculography study.
射血分数降低的心力衰竭患者血清纤维化标志物与心室充盈受限的关系:一项锝-99m放射性核素心室造影研究。
Oncotarget. 2017 Jan 10;8(2):2381-2390. doi: 10.18632/oncotarget.13795.
4
Suitable bone markers assessing bone status in patients with both coronary artery disease and diabetes.适用于评估冠心病合并糖尿病患者骨状态的骨标志物。
J Diabetes Metab Disord. 2016 Sep 6;15(1):35. doi: 10.1186/s40200-016-0259-1. eCollection 2015.
5
Cell death and serum markers of collagen metabolism during cardiac remodeling in Cavia porcellus experimentally infected with Trypanosoma cruzi.实验性感染克氏锥虫后豚鼠心脏重构过程中的细胞死亡和胶原代谢的血清标志物。
PLoS Negl Trop Dis. 2013;7(2):e1996. doi: 10.1371/journal.pntd.0001996. Epub 2013 Feb 7.
6
Biomarkers in acutely decompensated heart failure with preserved or reduced ejection fraction.急性失代偿性心力衰竭伴射血分数保留或降低的生物标志物。
Am Heart J. 2012 Nov;164(5):763-770.e3. doi: 10.1016/j.ahj.2012.08.014. Epub 2012 Oct 16.
7
Collagenous and non-collagenous biochemical markers of bone metastases from prostate cancer.前列腺癌骨转移的胶原和非胶原生化标志物
Hippokratia. 2010 Jul;14(3):164-9.
8
The relationship between aminoterminal propeptide of type III procollagen and heart rate variability parameters in heart failure patients: a potential serum marker to evaluate cardiac autonomic control and sudden cardiac death.III 型前胶原氨基末端肽与心力衰竭患者心率变异性参数的关系:评估心脏自主控制和心脏性猝死的潜在血清标志物。
Clin Chem Lab Med. 2010 Dec;48(12):1821-7. doi: 10.1515/CCLM.2010.348. Epub 2010 Sep 17.
9
Relations of biomarkers of extracellular matrix remodeling to incident cardiovascular events and mortality.细胞外基质重塑生物标志物与心血管事件和死亡率的关系。
Arterioscler Thromb Vasc Biol. 2010 Nov;30(11):2283-8. doi: 10.1161/ATVBAHA.110.208462. Epub 2010 Aug 26.
10
Cytokines and matrix metalloproteinases as potential biomarkers in chronic heart failure.细胞因子和基质金属蛋白酶作为慢性心力衰竭的潜在生物标志物
Biomark Med. 2009 Oct 1;3(5):513-523. doi: 10.2217/bmm.09.60.